Your browser is no longer supported. Please, upgrade your browser.
Settings
CBPO China Biologic Products Holdings, Inc. daily Stock Chart
CBPO [NASD]
China Biologic Products Holdings, Inc.
Index- P/E27.70 EPS (ttm)3.36 Insider Own44.13% Shs Outstand39.23M Perf Week-0.45%
Market Cap3.65B Forward P/E19.73 EPS next Y4.71 Insider Trans0.00% Shs Float21.59M Perf Month-1.47%
Income117.50M PEG3.03 EPS next Q1.03 Inst Own46.50% Short Float4.87% Perf Quarter-4.17%
Sales466.90M P/S7.81 EPS this Y-13.70% Inst Trans-0.79% Short Ratio5.87 Perf Half Y15.69%
Book/sh44.54 P/B2.09 EPS next Y9.42% ROA- Target Price87.29 Perf Year-8.00%
Cash/sh23.55 P/C3.95 EPS next 5Y9.13% ROE- 52W Range60.08 - 105.50 Perf YTD22.51%
Dividend- P/FCF42.13 EPS past 5Y11.00% ROI7.00% 52W High-11.85% Beta1.26
Dividend %- Quick Ratio10.30 Sales past 5Y18.10% Gross Margin68.60% 52W Low54.79% ATR1.79
Employees2187 Current Ratio12.60 Sales Q/Q15.40% Oper. Margin- RSI (14)45.57 Volatility1.69% 1.95%
OptionableYes Debt/Eq0.00 EPS Q/Q19.30% Profit Margin- Rel Volume1.64 Prev Close93.64
ShortableYes LT Debt/Eq0.00 EarningsAug 02 AMC Payout0.00% Avg Volume179.11K Price93.00
Recom3.40 SMA20-1.48% SMA500.38% SMA20010.81% Volume293,356 Change-0.68%
Mar-11-19Downgrade Jefferies Hold → Underperform $67 → $62
Nov-05-18Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-06-18Downgrade Credit Suisse Outperform → Neutral
May-14-18Downgrade Jefferies Buy → Hold
May-30-17Initiated Goldman Neutral
Mar-01-16Downgrade Credit Suisse Outperform → Neutral
Oct-08-15Initiated Credit Suisse Outperform
Jul-09-15Initiated BofA/Merrill Buy $135
Jul-08-14Reiterated Aegis Capital Buy $50 → $55
Mar-14-14Initiated Oppenheimer Outperform $46
Nov-06-13Downgrade Aegis Capital Buy → Hold
Mar-14-13Reiterated Aegis Capital Buy $22 → $28
May-13-10Reiterated Brean Murray Buy $19 → $20
Mar-26-10Reiterated Brean Murray Buy $15 → $19
May-13-19 12:23PM  China Biologic Products Inc (CBPO) Q1 2019 Earnings Call Transcript Motley Fool
May-10-19 05:45PM  China Biologic Products (CBPO) Tops Q1 Earnings and Revenue Estimates Zacks
04:41PM  China Biologic Products: 1Q Earnings Snapshot Associated Press
04:30PM  China Biologic Reports Financial Results for the First Quarter of 2019 PR Newswire
May-03-19 10:30AM  Earnings Preview: China Biologic Products (CBPO) Q1 Earnings Expected to Decline Zacks -5.58%
Apr-30-19 08:00AM  China Biologic Products to Report First Quarter 2019 Financial Results PR Newswire
Apr-27-19 09:07AM  Is China Biologic Products Inc (CBPO) A Good Stock To Buy According To Hedge Funds? Insider Monkey
Apr-26-19 10:30AM  Analysts Estimate China Biologic Products (CBPO) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-09-19 07:26AM  New Strong Sell Stocks for April 9th Zacks
Apr-04-19 09:19AM  New Strong Sell Stocks for April 4th Zacks
Mar-22-19 04:10AM  New Strong Sell Stocks for March 22nd Zacks
Mar-20-19 07:23AM  New Strong Sell Stocks for March 20th Zacks
Mar-18-19 10:47AM  New Strong Sell Stocks for March 18th Zacks
Mar-07-19 03:21PM  China Biologic Products Inc (CBPO) Q4 2018 Earnings Conference Call Transcript Motley Fool
Mar-06-19 05:00PM  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018 PR Newswire
Feb-25-19 08:00AM  China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results PR Newswire
Feb-04-19 01:06PM  Dalton Investments Return, AUM, and Holdings Insider Monkey
Jan-07-19 08:00AM  China Biologic Reiterates Full Year 2018 Financial Forecast PR Newswire
Dec-17-18 10:05AM  David Gao Issues Statement Following Decision by the Grand Court of the Cayman Islands Business Wire
Dec-14-18 08:00AM  China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman PR Newswire -6.50%
Dec-13-18 06:55AM  Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and China Biologic Products Holdings ACCESSWIRE
Nov-01-18 07:20PM  China Biologic Products: 3Q Earnings Snapshot Associated Press +5.03%
04:30PM  China Biologic Reports Financial Results for the Third Quarter of 2018 PR Newswire
Oct-24-18 08:00AM  China Biologic Products to Report Third Quarter 2018 Financial Results PR Newswire -5.65%
Oct-04-18 12:48PM  Investor Criticizes China Biologic Over Rejected Takeover Bid Bloomberg
Sep-26-18 07:50AM  Research Report Identifies The Carlyle Group, China Biologic Products, Ericsson, Dover, GasLog Partners LP, and Spectra Energy Partners, LP with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Sep-24-18 09:44AM  Is China Biologic Products Inc. (CBPO) A Good Stock To Buy? Centurium Capital Thinks So Insider Monkey
Aug-29-18 11:59AM  David Gao Confirms Lawsuit Against China Biologic Products to Protect Shareholders Best Interests Business Wire
Aug-28-18 05:00PM  China Biologic Responds to Lawsuit Filed in Cayman Islands by Former Chairman PR Newswire
Aug-24-18 01:47PM  China Biologic rejects $3.9 bln bid from former CEO Reuters -15.85%
12:35PM  Leading Investor Group Issues Statement Following China Biologics Dilutive Private Placement of Shares Business Wire
11:43AM  [$$] China Biologic Says One Buyout Offer Is Withdrawn, Rejects Another The Wall Street Journal
11:26AM  Here's Why China Biologic Products Stock Dropped Today Motley Fool
10:43AM  BRIEF-PW Medtech Group To Purchase 800,000 China Biologic Products Shares For $80.72 Mln Reuters
08:17AM  China Biologic rejects former CEO-led consortium's offer Reuters
08:00AM  China Biologic Announces Updates on Unsolicited Acquisition Proposals and Strategic Private Placement PR Newswire
Aug-21-18 04:05PM  Deals of the day-Mergers and acquisitions Reuters
08:00AM  Today's Research Reports on Trending Tickers: Cronos and China Biologic Products ACCESSWIRE
08:00AM  China Biologic Announces Receipt of Competing Non-Binding Acquisition Proposal PR Newswire
04:46AM  China Biologic gets $3.9 bln offer from former CEO-led consortium Reuters
Aug-20-18 01:52PM  Here's Why China Biologic Products Stock Is Soaring Today Motley Fool +8.71%
01:35PM  China Biologic gets $3.9 billion offer from former CEO-led consortium Reuters
12:26PM  UPDATE 1-China Biologic gets $3.9 bln offer from former CEO-led consortium Reuters
08:38AM  Consortium seeks to acquire China Biologic Products for $3.9 billion in cash MarketWatch
08:30AM  Leading Investor Group Proposes to Acquire China Biologic Products for US$118.00 Per Share in Cash Business Wire
Aug-13-18 08:00AM  China Biologic Names Bing Li as New CEO PR Newswire
Aug-03-18 04:40PM  China Biologic Products: 2Q Earnings Snapshot Associated Press
04:30PM  China Biologic Reports Financial Results for the Second Quarter of 2018 PR Newswire
Jul-27-18 08:00AM  China Biologic Products to Report Second Quarter 2018 Financial Results PR Newswire
Jul-10-18 02:31AM  Ping An Said to Mull Rival Takeover Offer for China Biologic Bloomberg +6.57%
Jul-02-18 08:30AM  China Biologic Announces Results of Its 2018 Annual General Meeting of Shareholders PR Newswire
Jun-22-18 02:47AM  Ex-Warburg Pincus China head targets up to $1.5 bln for China fund - sources Reuters
Jun-19-18 08:10AM  Todays Research Reports on Stocks to Watch: JD.com and China Biologic Products ACCESSWIRE
08:00AM  China Biologic Announces Receipt of Non-Binding Acquisition Proposal PR Newswire
Jun-18-18 05:32PM  WeissLaw LLP Investigates China Biologic Products Holdings, Inc. PR Newswire +21.15%
12:41PM  Here's Why China Biologic Products Holdings Inc. Soared as Much as 25.8% Today Motley Fool
09:42AM  Stocks Slide; Intel Downgraded; JD.com Spikes On Google Deal Investor's Business Daily
07:12AM  CITIC Capital offers to buy China Biologic for $110 per share Reuters
06:52AM  Investment firm CITIC Capital offers to buy China Biologic Products Reuters
Jun-11-18 08:00AM  China Biologic Receives CFDA Clinical Trial Approval for Human Fibrin Sealant PR Newswire
Jun-06-18 08:20AM  Analysis: Positioning to Benefit within China Biologic Products, Merus N.V, Adient, G1 Therapeutics, Westport Fuel, and AppFolio Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-31-18 02:58PM  Was China Biologic Products Holdings Incs (NASDAQ:CBPO) Earnings Decline Part Of A Broader Industry Downturn? Simply Wall St.
May-08-18 07:00AM  Blog Exposure - Portola Pharma Receives Approval from FDA for Its Lead Candidate ACCESSWIRE
May-04-18 04:37PM  China Biologic Products: 1Q Earnings Snapshot Associated Press
04:30PM  China Biologic Reports Financial Results for the First Quarter of 2018 PR Newswire
Apr-30-18 11:06AM  Is There An Opportunity With China Biologic Products Holdings Incs (NASDAQ:CBPO) 39% Undervaluation? Simply Wall St.
Apr-27-18 02:34PM  Has China Biologic Products Holdings Inc (NASDAQ:CBPO) Got Enough Cash? Simply Wall St.
Apr-13-18 07:45AM  Investor Expectations to Drive Momentum within Criteo S.A, Prima BioMed, CoStar Group, DBV Technologies S.A, Hollysys Automation Technologies, and China Biologic Products Discovering Underlying Factors of Influence GlobeNewswire
Mar-16-18 08:15AM  Recent Analysis Shows Clementia Pharmaceuticals, MyoKardia, Landec, Sapiens International Corporation N.V, AppFolio, and China Biologic Products Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Feb-28-18 05:00PM  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2017 PR Newswire
Feb-23-18 08:00AM  China Biologic Products to Report Fourth Quarter and Fiscal Year 2017 Financial Results PR Newswire
Feb-14-18 08:30AM  China Biologic to Build New Collection Station in Hainan Province PR Newswire
Feb-09-18 12:52PM  Should You Expect China Biologic Products Holdings Inc (NASDAQ:CBPO) To Continue Delivering An ROE Of 20.70%? Simply Wall St.
Jan-08-18 04:32PM  Has China Biologic Products Holdings Inc (NASDAQ:CBPO) Improved Earnings Growth In Recent Times? Simply Wall St.
08:00AM  China Biologic to Attend the 36th Annual J.P. Morgan Healthcare Conference PR Newswire
08:00AM  China Biologic Announces Corporate Update PR Newswire
Jan-03-18 08:06AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
06:00AM  China Biologic Announces Completion of Acquisition of TianXinFu from PWM PR Newswire
Jan-01-18 01:55PM  How Do Analysts See China Biologic Products Holdings Inc (NASDAQ:CBPO) Performing Over The Next Few Years? Simply Wall St.
Dec-29-17 12:52PM  China Biologic Products Holdings, Inc. Value Analysis (NASDAQ:CBPO) : December 29, 2017 Capital Cube
Dec-28-17 07:20AM  China Biologic Products Holdings, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : December 28, 2017 Capital Cube
Dec-22-17 03:55PM  Should You Be Tempted To Buy China Biologic Products Holdings Inc (NASDAQ:CBPO) Because Of Its PE Ratio? Simply Wall St.
Dec-15-17 08:30AM  China Biologic Receives Operating Permit for New Collection Facility in Ju County in Shandong Province PR Newswire
Dec-07-17 02:03PM  Has China Biologic Products Holdings Inc (CBPO) Got Enough Cash To Cover Its Short-Term Obligations? Simply Wall St.
Dec-04-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-22-17 08:20PM  What Do Analysts Think About China Biologic Products Holdings Incs (CBPO) Growth? Simply Wall St.
Nov-21-17 08:08AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-20-17 08:07AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-15-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-14-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-08-17 03:59PM  Calculating The Intrinsic Value Of China Biologic Products Holdings Inc (CBPO) Simply Wall St.
Nov-07-17 09:52AM  ETFs with exposure to China Biologic Products Holdings, Inc. : November 7, 2017 Capital Cube
Nov-02-17 05:47AM  China Biologic Products posts 3Q profit Associated Press
Nov-01-17 04:30PM  China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017 PR Newswire
Oct-27-17 10:48AM  ETFs with exposure to China Biologic Products Holdings, Inc. : October 27, 2017 Capital Cube
Oct-26-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Oct-25-17 08:00AM  China Biologic Products to Report Third Quarter of 2017 Financial Results PR Newswire
Oct-13-17 10:36AM  ETFs with exposure to China Biologic Products Holdings, Inc. : October 13, 2017 Capital Cube
08:36AM  China Biologic Products Holdings, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : October 13, 2017 Capital Cube
08:00AM  China Biologic Products Announces Conference Call to Discuss TianXinFu Acquisition PR Newswire
China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also provides human immunoglobulin and IVIG for original and secondary immunoglobulin deficiency, and immunoglobulin G secondary deficiency; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus. In addition, it offers placenta polypeptide for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia, as well as assists in postoperative healing; factor VIII for treating coagulopathies; human fibrinogen; and human prothrombin complex concentrate for treating congenital and acquired clotting factor II, VII, IX, X deficiency, as well as excessive anticoagulant, vitamin K deficiency, etc. Further, the company is developing Human fibrinogen for the treatment for lack of fibrinogen and increase human fibrinogen concentration; and artificial dura and spinal dura mater products for use in brain and spinal surgeries. The company sells its products directly, as well as through distributors. The company was formerly known as China Biologic Products, Inc. and changed its name to China Biologic Products Holdings, Inc. in July 2017. China Biologic Products Holdings, Inc. is headquartered in Beijing, the People's Republic of China.